• Latest Posts

PEP-Therapy Raised €1.3 Million in Seed Capital

Ynsect: what’s behind this Yellow Biotech champion?

Interview with Dr. Andrei Popov, CEO at Ecrins Therapeutics

Erytech Strengthens its Intellectual Property Position in the US

Annette Clancy joins Lysogene’s Board of Directors

Histalim, already 10 years committed to Histology

ADVERTISEMENT

Will the roads of the future be paved with microalgae?

Novacyt raised €2.2M to accelerate its technology’s launching in China

Ipsen and Hannover Medical School start joint research in Recombinant Botulinum Neurotoxins

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

Interview with CELLPROTHERA, the regenerative medicine pioneer

ADVERTISEMENT